Bianca E. Rich

Bianca E. Rich

Auto-generated profile, based on publicly available information

Bianca E. Rich

School of Medicine, University of Utah, Salt Lake City, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
WZWeiquan Zhu
Weiquan Zhu
DSDallas S. Shi
Dallas S. Shi
JWJacob M. Winter
Jacob M. Winter
BRBianca E. Rich
Bianca E. Rich
ZTZongzhong Tong
Zongzhong Tong
DLDean Y. Li
Dean Y. Li
The devastating sequelae of diabetes mellitus include microvascular permeability, which results in retinopathy. Despite clinical and scientific advances, there remains a need for new approaches to treat retinopathy. Here, we have presented a possible treatment strategy, whereby targeting the small GTPase ARF6 alters VEGFR2 trafficking and reverses signs of pathology in 4 animal models that represent features of diabetic retinopathy and in a fifth model of ocular pathological angiogenesis. Specifically, we determined that the same signaling pathway utilizes distinct GEFs to sequentially activate ARF6, and these GEFs exert distinct but complementary effects on VEGFR2 trafficking and signal transduction. ARF6 activation was independently regulated by 2 different ARF GEFs — ARNO and GEP100. Interaction between VEGFR2 and ARNO activated ARF6 and stimulated VEGFR2 internalization, whereas a VEGFR2 interaction with GEP100 activated ARF6 to promote VEGFR2 recycling via coreceptor binding. Intervening in either pathway inhibited VEGFR2 signal output. Finally, using a combination of in vitro, cellular, genetic, and pharmacologic techniques, we demonstrated that ARF6 is pivotal in VEGFR2 trafficking and that targeting ARF6-mediated VEGFR2 trafficking has potential as a therapeutic approach for retinal vascular diseases such as diabetic retinopathy.

21 December 2016 in Small GTPases
Verified
Journal Article
Closed access
AGAllie H. Grossmann
Allie H. Grossmann
HZHelong Zhao
Helong Zhao
NJNoah Jenkins
Noah Jenkins
WZWeiquan Zhu
Weiquan Zhu
JRJackson R. Richards
Jackson R. Richards
SOShannon J. Odelberg
Shannon J. Odelberg
The activation of the small GTPase ARF6 has been implicated in promoting several pathological processes related to vascular instability and tumor formation, growth, and metastasis. ARF6 also plays a vital role during embryonic development. Recent studies have suggested that ARF6 carries out these disparate functions primarily by controlling protein trafficking within the cell. ARF6 helps direct proteins to intracellular or extracellular locations where they function in normal cellular responses during development and in pathological processes later in life. This transport of proteins is accomplished through a variety of mechanisms, including endocytosis and recycling, microvesicle release, and as yet uncharacterized processes. This Commentary will explore the functions of ARF6, while focusing on the role of this small GTPase in development and postnatal physiology, regulating barrier function and diseases associated with its loss, and tumor formation, growth, and metastasis.

26 May 2022 in International Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
ASAshley M. Snyder
Ashley M. Snyder
ABAdelheid U. Brandenberger
Adelheid U. Brandenberger
VTVanina L. Taliercio
Vanina L. Taliercio
BRBianca E. Rich
Bianca E. Rich
LWLisa B. Webber
Lisa B. Webber
ASAaron M. Secrest
Aaron M. Secrest

4 October 2021 in JMIR Dermatology
Verified
Journal Article
Open access
ASAshley M Snyder
Ashley M Snyder
VTVanina L Taliercio
Vanina L Taliercio
ABAdelheid U Brandenberger
Adelheid U Brandenberger
BRBianca E Rich
Bianca E Rich
LWLisa B Webber
Lisa B Webber
ASAaron M Secrest
Aaron M Secrest
Background: Pain is an underappreciated symptom of atopic dermatitis that can affect the health-related quality of life (HRQL) of patients. Objective: The aim of this study is to understand the effect of pain on patients with atopic dermatitis and their family members and to recognize how this symptom affects HRQL. Methods: We conducted focus groups and interviews with patients with atopic dermatitis and their family members. Researchers independently coded the transcripts and reached a consensus on the major themes. Results: A total of 33 adult participants, consisting of 21 patients with atopic dermatitis (median age 47 years, range 22-77) and 12 family members (median age 50, range 22-72), attended either focus groups (23/33, 70%) or interviews (10/33, 30%), where we assessed their experiences of pain. Four themes emerged in our study. Itchiness and pain can be intertwined: pain was often caused by or otherwise associated with itchiness and could result from open sores and excoriated skin. Characteristics of pain: pain was most often described as burning. Other descriptors included mild, persistent discomfort; stinging; and stabbing. Effects of pain: pain negatively affected various aspects of daily life, including choice of clothing, sleep, social activities, and relationships. The location of painful areas could also limit physical activity, including sex. Pain management: pain from atopic dermatitis could be managed to varying degrees with different over-the-counter and prescription treatments. Systemic agents that cleared the skin also resolved the pain associated with atopic dermatitis. Conclusions: Pain can be a significant factor in the HRQL of patients with atopic dermatitis and should be considered by clinicians when caring for patients with atopic dermatitis.

22 April 2021 in JMIR Preprints
Verified
Preprint
Open access
ASAshley M Snyder
Ashley M Snyder
VTVanina L Taliercio
Vanina L Taliercio
ABAdelheid U Brandenberger
Adelheid U Brandenberger
BRBianca E Rich
Bianca E Rich
LWLisa B Webber
Lisa B Webber
ASAaron M Secrest
Aaron M Secrest
BACKGROUND Pain is an underappreciated symptom of atopic dermatitis that can affect the health-related quality of life (HRQL) of patients. OBJECTIVE The aim of this study is to understand the effect of pain on patients with atopic dermatitis and their family members and to recognize how this symptom affects HRQL. METHODS We conducted focus groups and interviews with patients with atopic dermatitis and their family members. Researchers independently coded the transcripts and reached a consensus on the major themes. RESULTS A total of 33 adult participants, consisting of 21 patients with atopic dermatitis (median age 47 years, range 22-77) and 12 family members (median age 50, range 22-72), attended either focus groups (23/33, 70%) or interviews (10/33, 30%), where we assessed their experiences of pain. Four themes emerged in our study. Itchiness and pain can be intertwined: pain was often caused by or otherwise associated with itchiness and could result from open sores and excoriated skin. Characteristics of pain: pain was most often described as burning. Other descriptors included mild, persistent discomfort; stinging; and stabbing. Effects of pain: pain negatively affected various aspects of daily life, including choice of clothing, sleep, social activities, and relationships. The location of painful areas could also limit physical activity, including sex. Pain management: pain from atopic dermatitis could be managed to varying degrees with different over-the-counter and prescription treatments. Systemic agents that cleared the skin also resolved the pain associated with atopic dermatitis. CONCLUSIONS Pain can be a significant factor in the HRQL of patients with atopic dermatitis and should be considered by clinicians when caring for patients with atopic dermatitis.

1 October 2019 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
AEAlexandra A. Eisenbeiss
Alexandra A. Eisenbeiss
BRBianca E. Rich
Bianca E. Rich
JBJustin R. Brunson
Justin R. Brunson
JLJohn T. Langell
John T. Langell